A 3-minute video and quick-reference list of October's 7 FDA cancer approvals, with the biomarker and monitoring points nurses need for each.
|Articles|July 1, 2015
Jill Stopfer on the Benefits of Multigene Panel Testing
Author(s)Jill Stopfer, MS, CGC
Jill Stopfer, MS, CGC, Senior Genetic Counselor, Abramson Cancer Center, University of Pennsylvania, discusses the benefits of multigene panel testing.
Advertisement
Jill Stopfer, MS, CGC, Senior Genetic Counselor, Abramson Cancer Center, University of Pennsylvania, discusses the benefits of multigene panel testing.
Advertisement
Related to this article
Oral vitamin C did not slow clonal growth in the phase 2 EVITA trial but was linked to longer survival.
Kathryn Shady, PhD, RN, OCN, discusses research on emotional dissonance and vicarious trauma among hematology/oncology nurses.
Ellery Palanuk, MSN, RN, CN-BN, explains how navigators rely on multidisciplinary teams and tumor boards as breast cancer treatment evolves.
At EONS 2026, a City of Hope nurse practitioner explains how shifting immunotherapy from infusion to injection can free nurse and chair time.
Oncology nurses play a key role guiding patients about AI breast cancer risk assessment tools, dynamic re-testing, and individualized screening plans.
Dana-Farber nurse practitioners outline ADC patient selection, sequencing, ILD surveillance, and patient education from JADPRO Live 2026.
Dr. Andrew Pecora on leading the first IV oncolytic virus trial, building a top-50 cancer center, and using AI to fix the cost of cancer care.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
October 2026 FDA Approvals: 7 Cancer Updates for Oncology Nurses
2
How Oncology Nurses Can Overcome Common Barriers to Research
3
What Nurses Should Tell Patients About Vitamin C in CCUS and MDS
4
Vicarious Trauma Affects Oncology Nurses in Every Care Setting
5